Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Non Operating Income (2021 - 2025)

Senti Biosciences has reported Non Operating Income over the past 5 years, most recently at $200000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 2.91% year-over-year to $200000.0; the TTM value through Dec 2025 reached $1.3 million, up 540.3%, while the annual FY2025 figure was $800000.0, 300.0% up from the prior year.
  • Non Operating Income for Q4 2025 was $200000.0 at Senti Biosciences, up from -$1.2 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $7.3 million in Q3 2023 and troughed at -$3.0 million in Q2 2021.
  • A 5-year average of $380000.0 and a median of $8000.0 in 2023 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: skyrocketed 362950.0% in 2023 and later plummeted 10609.09% in 2025.
  • Year by year, Non Operating Income stood at -$10000.0 in 2021, then soared by 60.0% to -$4000.0 in 2022, then surged by 350.0% to $10000.0 in 2023, then surged by 1960.0% to $206000.0 in 2024, then decreased by 2.91% to $200000.0 in 2025.
  • Business Quant data shows Non Operating Income for SNTI at $200000.0 in Q4 2025, -$1.2 million in Q3 2025, and $2.1 million in Q2 2025.